Acceleron Pharma Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 57,230 15,254 80,911
Cost of Revenue - - 1,500
Gross Profit 57,230 15,254 79,411
Operating Expenses
Research and Development 36,051 35,319 32,713
Sales, General and Admin. 14,227 8,824 8,142
Non-Recurring Items - - -
Other - - -
Operating Income 6,952 (28,889) 38,556
Income From Continuing Operations
Add'l Income/Expense Items (26,758) (2,164) (468)
Earnings Before Interest and Tax (19,806) (31,053) 38,088
Interest Expense 2,092 1,529 1,822
Earnings Before Tax (21,898) (32,582) 36,266
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (21,898) (32,582) 36,266
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (21,898) (32,582) 36,266
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (21,898) (32,582) 36,266